| http://purl.uniprot.org/citations/31260151 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/31260151 | http://www.w3.org/2000/01/rdf-schema#comment | "HtrA3 is a proapoptotic protease shown to promote drug-induced cytotoxicity in lung cancer cells and proposed to have an antitumor effect. However, at the molecular level, the role of HtrA3 in cell death induction is poorly understood. There are two HtrA3 isoforms, a long and a short one, termed HtrA3L and HtrA3S. By performing pull down assays, co-immunoprecipitation and ELISA, we showed that HtrA3 formed complexes with the X-linked inhibitor of apoptosis protein (XIAP). The recombinant HtrA3 variants ΔN-HtrA3L and -S, lacking the N-terminal regions that are not essential for protease activity, cleaved XIAP with a comparable efficiency, though ΔN-HtrA3S was more active in the presence of cellular extract, suggesting the existence of an activating factor. Immunofluorescence and proximity ligation assays indicated that HtrA3 partially co-localized with XIAP. Exogenous ΔN-HtrA3L/S promoted apoptotic death of lung cancer cells treated with etoposide and caused a significant decrease of cellular XIAP levels, in a way dependent on HtrA3 proteolytic activity. These results collectively indicate that both HtrA3 isoforms stimulate drug-induced apoptotic death of lung cancer cells via XIAP cleavage and thus help to understand the molecular mechanism of HtrA3 function in apoptosis and in cancer cell death caused by chemotherapy."xsd:string |
| http://purl.uniprot.org/citations/31260151 | http://purl.org/dc/terms/identifier | "doi:10.1111/febs.14977"xsd:string |
| http://purl.uniprot.org/citations/31260151 | http://purl.uniprot.org/core/author | "Lipinska B."xsd:string |
| http://purl.uniprot.org/citations/31260151 | http://purl.uniprot.org/core/author | "Filipek A."xsd:string |
| http://purl.uniprot.org/citations/31260151 | http://purl.uniprot.org/core/author | "Jarzab M."xsd:string |
| http://purl.uniprot.org/citations/31260151 | http://purl.uniprot.org/core/author | "Wenta T."xsd:string |
| http://purl.uniprot.org/citations/31260151 | http://purl.uniprot.org/core/author | "Zurawa-Janicka D."xsd:string |
| http://purl.uniprot.org/citations/31260151 | http://purl.uniprot.org/core/author | "Rychlowski M."xsd:string |
| http://purl.uniprot.org/citations/31260151 | http://purl.uniprot.org/core/author | "Jurewicz E."xsd:string |
| http://purl.uniprot.org/citations/31260151 | http://purl.uniprot.org/core/date | "2019"xsd:gYear |
| http://purl.uniprot.org/citations/31260151 | http://purl.uniprot.org/core/name | "FEBS J"xsd:string |
| http://purl.uniprot.org/citations/31260151 | http://purl.uniprot.org/core/pages | "4579-4596"xsd:string |
| http://purl.uniprot.org/citations/31260151 | http://purl.uniprot.org/core/title | "The HtrA3 protease promotes drug-induced death of lung cancer cells by cleavage of the X-linked inhibitor of apoptosis protein (XIAP)."xsd:string |
| http://purl.uniprot.org/citations/31260151 | http://purl.uniprot.org/core/volume | "286"xsd:string |
| http://purl.uniprot.org/citations/31260151 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/31260151 |
| http://purl.uniprot.org/citations/31260151 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/31260151 |
| http://purl.uniprot.org/uniprot/#_P83110-mappedCitation-31260151 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/31260151 |
| http://purl.uniprot.org/uniprot/P83110 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/31260151 |